CDKN2A and lymphoma: The hypermethylation of CDKN2A (p16) promotes uncontrolled fibroblast proliferation and RASSF1A silencing via DNA methylation which prevents apoptosis and plays a important role in cell-cycle arrest and is implicated in the development of a number of different cancers including lymphomas [134,135].